Anzeige
❌
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche
Realtimekurse aktiv

WKN: A12EKB | ISIN: CA09073K1084 | Ticker-Symbol: 20B
Stuttgart
02.04.25
21:58 Uhr
0,155 Euro
-0,005
-3,12 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMARK DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
BIOMARK DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1490,18902.04.

Aktuelle News zur BIOMARK DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoBiomark Diagnostics Inc: Biomark closes $4.26-million private placement1Stockwatch
MoBioMark Diagnostics, Inc.: BioMark Announces the Final Closing of Oversubscribed Private Placement174NewsfileVancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early cancer...
► Artikel lesen
26.03.Biomark Diagnostics Inc: Biomark closes $2.88-million financing tranche1Stockwatch
26.03.BioMark Diagnostics, Inc.: BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform297NewsfileVancouver, British Columbia--(Newsfile Corp. - March 26, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) ("BioMark"), a leading developer of liquid biopsy tests for early cancer detection, is...
► Artikel lesen
28.02.BioMark Diagnostics, Inc.: BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025350NewsfileVancouver, British Columbia--(Newsfile Corp. - February 28, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early...
► Artikel lesen
11.12.24Biomark Diagnostics Inc: Biomark talks breast cancer diagnostic capabilities4Stockwatch
BIOMARK DIAGNOSTICS Aktie jetzt für 0€ handeln
10.12.24BioMark Diagnostics, Inc.: BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction374NewsfileVancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leader in liquid biopsy tests for early cancer detection...
► Artikel lesen
05.11.24Biomark Diagnostics Inc: Biomark boasts of liquid biopsy platform detection4Stockwatch
05.11.24BioMark Diagnostics, Inc.: BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection335NewsfileVancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early...
► Artikel lesen
24.09.24BioMark Diagnostics, Inc.: BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN393NewsfileVancouver, British Columbia--(Newsfile Corp. - September 24, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
10.09.24BioMark Diagnostics, Inc.: BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection256NewsfileVancouver, British Columbia--(Newsfile Corp. - September 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
26.08.24BioMark Diagnostics, Inc.: Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright's 26th Annual Global Investment Conference in New York565NewsfileVancouver, British Columbia--(Newsfile Corp. - August 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF), a leading developer of liquid biopsy tests for early cancer detection...
► Artikel lesen
31.07.24BioMark Diagnostics, Inc.: The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay430NewsfileVancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - BioMark Diagnostics Inc., (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy...
► Artikel lesen
15.07.24BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference639NewsfileVancouver, British Columbia--(Newsfile Corp. - July 15, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy tests...
► Artikel lesen
18.04.24BioMark Diagnostics, Inc.: BioMark Announces Warrant Extension and Granting of Options535NewsfileVancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...
► Artikel lesen
09.04.24BioMark Diagnostics, Inc.: BioMark to Advance Development of Cancer Treatment for Glioblastoma352NewsfileVancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen